Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Irritable Bowel Syndrome, February 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 50 articles:
HTML format


 

Single Articles

  1. BLASZKOWSKA J, Goralska K
    Clinical cases of parasitoses and fungal infections important from medical point of view
    Ann Parasitol. 2016;62:255-265.
    Abstract    

    Abstract available

  2. TAMANAI-SHACOORI Z, Smida I, Bousarghin L, Loreal O, et al
    Roseburia spp.: a marker of health?
    Future Microbiol. 2017;12:157-170.
    Abstract    

    Abstract available

  3. OSWIECIMSKA J, Szymlak A, Roczniak W, Girczys-Poledniok K, et al
    New insights into the pathogenesis and treatment of irritable bowel syndrome.
    Adv Med Sci. 2017;62:17-30.
    Abstract    

    Abstract available

  4. PEARSON JS, Whorwell PJ
    Progress with treating the microbial dysbiosis associated with irritable bowel syndrome.
    Curr Opin Gastroenterol. 2017;33:21-25.
    Abstract    

    Abstract available

  5. MALIKOWSKI T, Khanna S, Pardi DS
    Fecal microbiota transplantation for gastrointestinal disorders.
    Curr Opin Gastroenterol. 2017;33:8-13.
    Abstract    

    Abstract available

  6. ROMANA B, Tahan V
    Rifaximin in treatment of patients with Irritable bowel syndrome.
    Turk J Gastroenterol. 2017;28:77-78.
    Abstract    



  7. GOK EG, Inci A, Coban M, Kutsal DA, et al
    Functional bowel disorders and associated risk factors in hemodialysis patients in Turkey.
    Turk J Gastroenterol. 2017;28:12-19.
    Abstract    

    Abstract available

  8. THOMPSON J
    Improving clinical care for patients with irritable bowel syndrome.
    Br J Nurs. 2017;26:76-80.
    Abstract    

    Abstract available

  9. RIM TH, Kang MJ, Choi M, Seo KY, et al
    Ten-year incidence and prevalence of clinically diagnosed blepharitis in South Korea: A nationwide population-based cohort study.
    Clin Exp Ophthalmol. 2017 Feb 9. doi: 10.1111/ceo.12929.
    Abstract    

    Abstract available

  10. LIU HN, Wu H, Chen YZ, Chen YJ, et al
    Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis.
    Dig Liver Dis. 2017 Jan 21. pii: S1590-8658(17)30146.
    Abstract    

    Abstract available

  11. GREENWOOD-VAN MEERVELD B, Johnson AC, Grundy D
    Gastrointestinal Physiology and Function.
    Handb Exp Pharmacol. 2017 Feb 8. doi: 10.1007/164_2016.
    Abstract    

    Abstract available

  12. JOHNSON AC, Greenwood-Van Meerveld B
    Critical Evaluation of Animal Models of Gastrointestinal Disorders.
    Handb Exp Pharmacol. 2017 Feb 8. doi: 10.1007/164_2016.
    Abstract    

    Abstract available

  13. CHANG L, Heitkemper MM, Wiley JW, Camilleri M, et al
    2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome.
    Cell Mol Gastroenterol Hepatol. 2016;2:394-399.
    Abstract    



  14. MANSOURI A, Amini Rarani M, Fallahi M, Alvandi I, et al
    Irritable Bowel Syndrome is concentrated in people with higher educations in Iran: an inequality analysis.
    Epidemiol Health. 2017 Feb 1. doi: 10.4178/epih.e2017005.
    Abstract    

    Abstract available

  15. CULVER HR, Clegg JR, Peppas NA
    Analyte-Responsive Hydrogels: Intelligent Materials for Biosensing and Drug Delivery.
    Acc Chem Res. 2017 Feb 7. doi: 10.1021/acs.accounts.6b00533.
    Abstract    

    Abstract available

  16. FANT RV, Henningfield JE, Cash BD, Dove LS, et al
    Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea.
    Clin Gastroenterol Hepatol. 2017 Feb 3. pii: S1542-3565(17)30134.
    Abstract    

    Abstract available

  17. YUAN F, Ni H, Asche CV, Kim M, et al
    Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
    Curr Med Res Opin. 2017 Feb 6:1-17. doi: 10.1080/03007995.2017.1292230.
    Abstract    

    Abstract available

  18. PADHY SK, Mishra S, Sarkar S, Bang LG, et al
    Comparison of psychiatric morbidity in patients with irritable bowel syndrome and non-ulcer dyspepsia.
    Ind Psychiatry J. 2016;25:29-34.
    Abstract    

    Abstract available

  19. ZENG ZX, Wang H, Yang X
    [Advances in treatment of irritable bowel syndrome].
    Zhonghua Nei Ke Za Zhi. 2017;56:140-143.
    Abstract    



  20. D'ALCAMO A, Mansueto P, Soresi M, Iacobucci R, et al
    Contact Dermatitis Due to Nickel Allergy in Patients Suffering from Non-Celiac Wheat Sensitivity.
    Nutrients. 2017;9.
    Abstract    

    Abstract available

  21. MISHIMA T, Fukae J, Fujioka S, Inoue K, et al
    The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria.
    J Parkinsons Dis. 2017 Jan 30. doi: 10.3233/JPD-160982.
    Abstract    

    Abstract available

  22. FUKUDO S, Matsueda K, Haruma K, Ida M, et al
    Optimal dose of ramosetron in female patients with irritable bowel syndrome with diarrhea: A randomized, placebo-controlled phase II study.
    Neurogastroenterol Motil. 2017 Feb 16. doi: 10.1111/nmo.13023.
    Abstract    

    Abstract available

  23. LUCAK S, Chang L, Halpert A, Harris LA, et al
    Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice.
    Therap Adv Gastroenterol. 2017;10:253-275.
    Abstract    

    Abstract available

  24. BUONO JL, Carson RT, Flores NM
    Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.
    Health Qual Life Outcomes. 2017;15:35.
    Abstract    

    Abstract available

  25. GULERIA A, Karyampudi A, Singh R, Khetrapal CL, et al
    Mapping of Brain Activations to Rectal Balloon Distension Stimuli in Male Patients with Irritable Bowel Syndrome Using Functional Magnetic Resonance Imaging.
    J Neurogastroenterol Motil. 2017 Feb 14. doi: 10.5056/jnm16148.
    Abstract    

    Abstract available

  26. ZIELINSKA M, Fichna J, Bashashati M, Habibi S, et al
    G protein-coupled estrogen receptor and estrogen receptor ligands regulate colonic motility and visceral pain.
    Neurogastroenterol Motil. 2017 Feb 12. doi: 10.1111/nmo.13025.
    Abstract    

    Abstract available

  27. GUPTA A, Cole S, Labus JS, Joshi S, et al
    Gene expression profiles in peripheral blood mononuclear cells correlate with salience network activity in chronic visceral pain: A pilot study.
    Neurogastroenterol Motil. 2017 Feb 12. doi: 10.1111/nmo.13027.
    Abstract    

    Abstract available

  28. JEMBREK MJ, Auteri M, Serio R, Vlainic J, et al
    GABAergic system in action: connection to gastrointestinal stress-related disorders.
    Curr Pharm Des. 2017 Feb 9. doi: 10.2174/1381612823666170209155753.
    Abstract    

    Abstract available

  29. MEARIN F, Ciriza C, Minguez M, Rey E, et al
    [Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)].
    Semergen. 2017 Feb 8. pii: S1138-3593(17)30009.
    Abstract    

    Abstract available

  30. ZIELINSKA M, Jarmuz A, Wasilewski A, Cami-Kobeci G, et al
    Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.
    Pharmacol Rep. 2016;69:350-357.
    Abstract    

    Abstract available

  31. FIKREE A, Chelimsky G, Collins H, Kovacic K, et al
    Gastrointestinal involvement in the Ehlers-Danlos syndromes.
    Am J Med Genet C Semin Med Genet. 2017 Feb 10. doi: 10.1002/ajmg.c.31546.
    Abstract    

    Abstract available

  32. SEBASTIAN DOMINGO JJ
    Review of the role of probiotics in gastrointestinal diseases in adults.
    Gastroenterol Hepatol. 2017 Feb 6. pii: S0210-5705(17)30003.
    Abstract    

    Abstract available

  33. SHARMA A, Rao S
    Constipation: Pathophysiology and Current Therapeutic Approaches.
    Handb Exp Pharmacol. 2017 Feb 10. doi: 10.1007/164_2016.
    Abstract    

    Abstract available

  34. BROCHARD C, Venara A, Bodere A, Ropert A, et al
    Pathophysiology of fecal incontinence in obese patients: A prospective case-matched study of 201 patients.
    Neurogastroenterol Motil. 2017 Feb 23. doi: 10.1111/nmo.13051.
    Abstract    

    Abstract available

  35. KOTZE LM, Costa CT, Cavassani MF, Nisihara RM, et al
    Alert for bone alterations and low serum concentrations of vitamin D in patients with intestinal inflammatory disease.
    Rev Assoc Med Bras (1992). 2017;63:13-17.
    Abstract    

    Abstract available

  36. SUNDERLAND R
    Irritable bowel syndrome in adults: symptoms, treatment and management.
    Nurs Stand. 2017;31:52-63.
    Abstract    

    Abstract available

  37. RUSSO R, Cristiano C, Avagliano C, De Caro C, et al
    Gut-brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases.
    Curr Med Chem. 2017 Feb 16. doi: 10.2174/0929867324666170216113756.
    Abstract    

    Abstract available

  38. RAMAN M
    Testing for Chronic Diarrhea.
    Adv Clin Chem. 2017;79:199-244.
    Abstract    

    Abstract available

  39. EDEBOL-CARLMAN H, Ljotsson B, Linton SJ, Boersma K, et al
    Face-to-Face Cognitive-Behavioral Therapy for Irritable Bowel Syndrome: The Effects on Gastrointestinal and Psychiatric Symptoms.
    Gastroenterol Res Pract. 2017;2017:8915872.
    Abstract    

    Abstract available

  40. MANOLAKIS AC, Christodoulidis G, Kapsoritakis AN, Georgoulias P, et al
    alpha2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease.
    World J Gastroenterol. 2017;23:437-446.
    Abstract    

    Abstract available

  41. CREMON C, Stanghellini V, Barbaro MR, Cogliandro RF, et al
    Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2017 Feb 6. doi: 10.1111/apt.13958.
    Abstract    

    Abstract available

  42. PORTER CK, Welsh M, Riddle MS, Nieh C, et al
    Epidemiology of inflammatory bowel disease among participants of the Millennium Cohort: incidence, deployment-related risk factors, and antecedent episodes of infectious gastroenteritis.
    Aliment Pharmacol Ther. 2017 Feb 23. doi: 10.1111/apt.13991.
    Abstract    

    Abstract available

  43. LI ZY, Zhang N, Wen S, Zhang J, et al
    Decreased glucagon-like peptide-1 correlates with abdominal pain in patients with constipation-predominant irritable bowel syndrome.
    Clin Res Hepatol Gastroenterol. 2017 Feb 16. pii: S2210-7401(17)30006.
    Abstract    

    Abstract available

  44. RINGEL Y
    The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders.
    Gastroenterol Clin North Am. 2017;46:91-101.
    Abstract    

    Abstract available

  45. DINAN TG, Cryan JF
    The Microbiome-Gut-Brain Axis in Health and Disease.
    Gastroenterol Clin North Am. 2017;46:77-89.
    Abstract    

    Abstract available

  46. MURTAZA N, O Cuiv P, Morrison M
    Diet and the Microbiome.
    Gastroenterol Clin North Am. 2017;46:49-60.
    Abstract    

    Abstract available

  47. WOUTERS MM
    Novel insight in diarrhoea-predominant IBS: miRNAs modulate barrier function.
    Gut. 2017 Feb 9. pii: gutjnl-2016-313525. doi: 10.1136/gutjnl-2016-313525.
    Abstract    



  48. CHOI YJ, Kim N, Yoon H, Shin CM, et al
    Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses.
    J Gastroenterol Hepatol. 2017 Feb 4. doi: 10.1111/jgh.13756.
    Abstract    

    Abstract available

  49. NWOSU BU, Maranda L, Candela N
    Vitamin D status in pediatric irritable bowel syndrome.
    PLoS One. 2017;12:e0172183.
    Abstract    

    Abstract available

  50. KUO B, Bhasin M, Jacquart J, Scult MA, et al
    Correction: Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease.
    PLoS One. 2017;12:e0172872.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;